{"nct_id":"NCT02000817","title":"Investigation of Otelixizumab in New-Onset, Autoimmune Type 1 Diabetes Mellitus Patients","status":"COMPLETED","status_verified_date":"2019-03","start_date":"2014-03-12","start_date_type":"ACTUAL","primary_completion_date":"2018-09-27","primary_completion_date_type":"ACTUAL","completion_date":"2018-09-27","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["GSK"]}